Thalia Therapeutics

Default features description for sign up page.

Regulatory news

Home

Media

AIM Rule 26

Open Sans

THALIA THERAPEUTICS INVESTOR CENTRE

N4 Pharma recently presented at the ShareSoc Discovery Series on 25th February, providing an update on our strategy, Nuvec® technology, and upcoming milestones.

If you missed the chance to ask a question during the session, feel free to submit yours below—we’d love to hear from you.

ShareSoc Discovery Webinar Series - N4 Pharma